What Managed Care Needs to Know in the Evolving Treatment of Heart Failure: Novel Therapies for Improved Clinical and Economic Outcomes

 

What Managed Care Needs to Know in the Evolving Treatment of Heart Failure: Novel Therapies for Improved
Clinical and Economic Outcomes
is a 3-part webcast series that will provide attendees with the
latest information in Heart Failure treatment and management.

By clicking on each of the titles, you will be able to participate in each part.
It is not required that you participate in all 3 or in order.

These are archives of live webinars held between May 16, 2018 to June 20, 2018.

If you participated in any of the live webinars, you are not eligible
to claim credit from the archive of that webinar.

Each session has its own specific valid dates

Instructions for CME/CNE: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the posttest to receive continuing education credits. If you do not pass the posttest after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your posttest, you will automatically be given your certificate. To print or save your certificate, you will need to click on the “download” button and either print or save.

 

This series is supported by an educational grant from Novartis Pharmaceuticals Coporation

 

Description:

Heart failure (HF) is a common condition that affects approximately 5.7 million people in the United States, and the prognosis for patients with heart failure has traditionally been poor. HF is responsible for over one million hospitalizations in the U.S. per year which attributes to an estimated $31 billion in costs. While recent efforts have focused on improving the outlook for patients with chronic heart failure, mortality and morbidity following admission for acute heart failure remain significant. In recent decades, an improved understanding of the pathobiology of HF has led to the introduction of several new classes of medications that have shown improved clinical outcomes in patients with HF. Although these new and emerging therapeutic options have shown to lower mortality their application in clinical practice have been less than ideal as the 5-year mortality rate and patient readmissions for HF remain unacceptably high. In fact, HF is the leading cause of hospitalization among adults over the age of 65 in the U.S. Thus, it is critical that physicians and healthcare providers implement individualized treatment strategies, promote shared decision-making with patients and, ultimately, enhance patient quality of life.

 

A Deeper Look into the Newest Therapies in the Management of Heart Failure: Individualizing Therapy for Improved Clinical and Economic Outcomes

  • Describe the recently published guideline updates for emerging therapies in HF, including results from pivotal trials and evidence supporting averted HF-related hospitalizations and/or deaths

  • Summarize the mechanisms of action and different clinical attributes, including efficacy and safety, of newer and emerging therapies for the management of HF

  • Evaluate methods for individualizing chronic HF treatment strategies for patients based on specific patient-related factors to control symptoms, reduce hospitalizations, and prevent mortality in patients with reduced ejection fraction
    Physician, Nursing and CMCN credits valid to August 1, 2020

 

Comparative Effectiveness and Coordinated Care in Heart Failure: What Does Managed Care Need to Know about Novel Therapies?

  • Characterize the disease burden of HF in the managed care setting as determined by hospitalizations and other components of morbidity and mortality

  • Analyze what managed care and payers need to know about newer therapies in heart failure management

  • Discuss current economic and logistic barriers to appropriate HF therapy in the managed care setting

  • Apply methods to enable optimal cost management of newer heart failure therapy to be realized by multiple heart failure stakeholders including managed care organizations

    Physician, Nursing and CMCN credits valid to August 1, 2020

 

Improving Patient Adherence, Quality of Life and Transitions in Care in Heart Failure Management

  • Analyze strategies for reducing hospital readmissions for patients with chronic heart failure

  • Employ collaborative strategies for HF management enlisting the input and support of a multidisciplinary team of health care providers

  • Apply evidence-based and expert consensus strategies for patient-centered HF care, including patient/caregiver education, shared decision-making, self-care and self-monitoring, and adherence promotion

  • Discuss strategies to manage adverse events associated with newer therapies available for heart failure patients
    Physician, Nursing and CMCN credits valid to August 1, 2020